X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (655) 655
thienamycins - pharmacology (589) 589
microbiology (457) 457
microbial sensitivity tests (432) 432
pharmacology & pharmacy (430) 430
anti-bacterial agents - pharmacology (380) 380
index medicus (374) 374
imipenem (305) 305
male (293) 293
biochemical phenomena, metabolism, and nutrition (289) 289
meropenem (283) 283
beta-lactamases - metabolism (281) 281
polycyclic compounds (272) 272
female (265) 265
imipenem - pharmacology (254) 254
bacterial infections and mycoses (241) 241
thienamycins - metabolism (214) 214
thienamycins - pharmacokinetics (211) 211
thienamycins - therapeutic use (205) 205
infectious diseases (197) 197
animals (188) 188
adult (174) 174
middle aged (173) 173
thienamycins - administration & dosage (173) 173
bacteria (161) 161
carbapenems - pharmacology (159) 159
research article (155) 155
pseudomonas aeruginosa - drug effects (152) 152
antibiotics (151) 151
aged (149) 149
beta-lactamases - genetics (143) 143
kinetics (140) 140
anti-bacterial agents - therapeutic use (114) 114
cilastatin (110) 110
resistance (109) 109
anti-bacterial agents - pharmacokinetics (105) 105
bacterial proteins - metabolism (102) 102
bacterial infections - drug therapy (100) 100
pharmacokinetics (97) 97
pseudomonas-aeruginosa (95) 95
drug combinations (92) 92
anti-bacterial agents - metabolism (89) 89
escherichia-coli (89) 89
infections (88) 88
bacterial proteins - genetics (83) 83
drug resistance, microbial (80) 80
klebsiella pneumoniae - drug effects (79) 79
anti-bacterial agents - administration & dosage (78) 78
cephalosporins - pharmacology (76) 76
thienamycins - blood (74) 74
carbapenems (72) 72
escherichia coli - drug effects (71) 71
hydrolysis (70) 70
bacteria - drug effects (69) 69
thienamycins - adverse effects (69) 69
mice (68) 68
susceptibility (68) 68
child (67) 67
cyclopropanes - metabolism (64) 64
rats (64) 64
drug resistance, bacterial (63) 63
adolescent (62) 62
drug synergism (62) 62
mechanisms of resistance (62) 62
carbapenem (61) 61
cyclopropanes - administration & dosage (60) 60
enterobacteriaceae (59) 59
thienamycins - chemistry (59) 59
beta-lactam antibiotics (58) 58
infusions, intravenous (58) 58
gram-negative bacteria - drug effects (57) 57
pharmacology (57) 57
child, preschool (55) 55
pseudomonas infections - microbiology (55) 55
pseudomonas aeruginosa - enzymology (54) 54
thienamycin (54) 54
ceftazidime - pharmacology (53) 53
drug therapy, combination (53) 53
gram-negative bacteria (52) 52
klebsiella-pneumoniae (52) 52
penicillin-binding proteins (52) 52
bacterial proteins (51) 51
beta-lactam resistance (51) 51
beta-lactams - pharmacology (51) 51
biochemistry & molecular biology (51) 51
klebsiella pneumoniae - enzymology (51) 51
half-life (50) 50
infant (50) 50
enterobacteriaceae - drug effects (49) 49
emergence (48) 48
pseudomonas aeruginosa - genetics (48) 48
aged, 80 and over (47) 47
carbapenems - metabolism (47) 47
analysis (46) 46
ceftazidime (46) 46
imipenem - pharmacokinetics (46) 46
imipenem - therapeutic use (46) 46
pseudomonas infections - drug therapy (46) 46
beta-lactamase inhibitors (45) 45
research (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1036) 1036
Japanese (65) 65
Spanish (8) 8
German (5) 5
Polish (5) 5
French (4) 4
Russian (4) 4
Chinese (2) 2
Italian (2) 2
Turkish (2) 2
Croatian (1) 1
Hungarian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142352
Objective The gut microbiota has been designated as an active regulator of glucose metabolism and metabolic phenotype in a number of animal and human... 
BILE-ACID METABOLISM | VANCOMYCIN | METAGENOME | TOLERANCE | MULTIDISCIPLINARY SCIENCES | SENSATIONS | APPETITE | IMPACTS | INSULIN SENSITIVITY | MODULATION | REPRODUCIBILITY | Humans | Male | Vancomycin - metabolism | Diarrhea - chemically induced | Insulin - blood | Young Adult | Feces - microbiology | Gentamicins - metabolism | Time Factors | Fasting - blood | Gentamicins - pharmacology | Vancomycin - pharmacology | Gastrointestinal Hormones - metabolism | Postprandial Period | Adult | Anti-Bacterial Agents - adverse effects | Thienamycins - adverse effects | Gentamicins - adverse effects | Anti-Bacterial Agents - metabolism | Treatment Outcome | Bacterial Load | Thienamycins - pharmacology | Vancomycin - adverse effects | Thienamycins - metabolism | Feces - chemistry | Gastrointestinal Microbiome - drug effects | Adolescent | Glucose - metabolism | Anti-Bacterial Agents - pharmacology | Gastrointestinal Hormones - blood | Blood Glucose - metabolism | Gentamicin | Hormones | Vancomycin | Glucose | Males | Hormone release | Glucose metabolism | Body mass index | Microbiota | Rodents | Measurement methods | Bacteria | Blood pressure | Meropenem | Obesity | Cultivation | Secretion | Test procedures | Metabolism | Insulin | Fatty acids | Glucose tolerance | Hospitals | Antibiotics | Insulin resistance | Diabetes | Long-term effects
Journal Article
Journal Article
Molecular Microbiology, ISSN 0950-382X, 12/2017, Volume 106, Issue 6, pp. 919 - 937
Summary During environmental adaptation bacteria use small regulatory RNAs (sRNAs) to repress or activate expression of a large fraction of their proteome. We... 
SYSTEM | ACTIVATION | BACTERIA | PROTEIN | OPRD | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENE-EXPRESSION | RESISTANCE | MICROBIOLOGY | IDENTIFICATION | PREDICTION | DEACYLASE | Porins - metabolism | RNA, Messenger - metabolism | Type III Secretion Systems - genetics | Host Factor 1 Protein - metabolism | Regulon | Polymyxins - pharmacology | Pseudomonas aeruginosa - pathogenicity | Genes, Regulator - physiology | Trans-Activators - genetics | RNA, Small Untranslated - genetics | Meropenem | Drug Resistance, Bacterial - genetics | RNA, Small Untranslated - metabolism | Carbapenems - metabolism | Porins - genetics | Lipid A - metabolism | Bacterial Proteins - genetics | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Type III Secretion Systems - metabolism | Pseudomonas aeruginosa - genetics | Bacterial Proteins - metabolism | Trans-Activators - metabolism | Anti-Bacterial Agents - pharmacology | Gene Expression Regulation, Bacterial | Antibiotics | RNA | Analysis | Genetic research | Lipids | Genetic aspects | Genetic transcription | Investigations | Pathogens | Post-transcription | Target recognition | Secretion | Inflammation | Gene expression | Ribonucleic acid--RNA | Lipid A | Pathogenicity | 5' Untranslated Regions | Bacteria | Deacylation | Pseudomonas aeruginosa | In vivo methods and tests | PagL | regulation of T3SS | post-transcriptional regulation | OprD | sRNA
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2013, Volume 57, Issue 12, pp. 5940 - 5945
Journal Article
by Robert, Jérôme and Pantel, Alix and Merens, Audrey and Meiller, Elodie and Lavigne, Jean-Philippe and Nicolas-Chanoine, Marie-Hélène and Brieu, N and Vrain, A and Scanvic, A and Porcheret, H and Garnier, P and Bertrand, X and Descamps, D and Hombrouck, C and Soullié, B and Heym, B and Paul, J.G and de Montclos, H and Garrec, H and Levast, M and Mendes-Martins, L and Langeard, M and Decousser, J.W and Huet, C and Bert, F and Herzig, V and Klein, J.P and Nebbad, B and Hendricx, S and Verhaeghe, A and Lafaurie, C and Lanselle, C and Elsayed, F and Carrer, A and Drieux-Rouzet, L and Evreux, F and Varache, C and Wallet, F and Martin, C and Le-Bris, J.M and Moulhade, M.C and Deville, E and Menouni, O and Jean-Pierre, H and Mion, P and Pierrot, P and Delarbre, J.M and Coude, B and Foca, M and Degand, N and Prots, L and Pantel, Alix and Bret, L and Adam, M.N and Laurens, E and Raskine, L and Laouira, S and Arlet, G and Sanchez, R and Peuchant, O and Grau, V and Jaubert, J and Laurent, C and De-Champs, C and Vachée, A and Harriau, P and Schillinger, S and Belmonte, O and Michel, G and Merens, Audrey and Henry, C and Samaille, S and Picot, S and Violette, J and Glatz, I and Barrans, A and Gueudet, T and Honderlick, P and Cavalié, L and Galinier, J.L and Patoz, P and van-der-Mee-Marquet, N and Haguenoer, E and Canis, F and Kassis-Chikhany, N and Le-Garrec, Y and ONERBA's Carbapenem Resistance Stu and ONERBA’s carbapenem resistance study group and on behalf of ONERBA’s carbapenem resistance study group
BMC Infectious Diseases, ISSN 1471-2334, 01/2017, Volume 17, Issue 1, p. 78
Journal Article
Journal Article